Hochdorf: Newlat has fallen below the 3% participation mark

Hochdorf: Newlat has fallen below the 3% participation mark

Zurich (awp) – The curtain has fallen on Newlat: following the extraordinary general meeting where milk processor Hochdorf voted to sell the group’s operational activities, the Italian company has dropped below the 3% stake threshold, as announced by the Lucerne-based firm on Tuesday evening.

Newlat acquired a stake in Hochdorf in April and had increased its holdings to nearly 11%, becoming the largest shareholder of the Lucerne-based company. However, its attempts to gain control of the struggling firm were unsuccessful, including at the annual general meeting last May.

Subsequently, Newlat made an unsolicited takeover bid for Hochdorf Swiss Nutrition (HSS), but the Lucerne-based company stated that no binding offer was ever made.

Last Friday, the extraordinary general meeting finalized the decision and voted to sell HSN to AS Equity for 83 million Swiss francs, after deducting a consortium loan of 67 million, with the remaining 15.5 million going to the Lucerne holding company.

The proceeds from the sale are insufficient to settle the debts, and shareholders should anticipate a total loss. In the past month alone, the share price has plummeted by 90% to 70 cents. With a total of 2.15 million shares, the current market value is approximately 1.5 million Swiss francs.

tv/rp

Newlat’s Exit from Hochdorf: Implications for the Dairy Industry

The Recent Changes at Hochdorf

In a significant development in the Swiss dairy processing market, Newlat has officially reduced its stake in Hochdorf below the 3% mark, following the extraordinary general meeting where shareholders voted to sell the company’s operational activities.

Originally acquiring a stake in Hochdorf in April and becoming its largest shareholder at nearly 11%, Newlat’s aspirations to gain control over the struggling dairy processor faced numerous obstacles. Their efforts to influence decision-making have consistently failed, notably during the annual general meeting last May.

Unsolicited Takeover Attempt

After multiple unsuccessful attempts to gain control, Newlat resorted to making an unsolicited takeover offer for Hochdorf Swiss Nutrition (HSN). However, initial interest did not materialize into a binding offer, which has since raised concerns for shareholders about potential future involvement from Newlat.

Sale of Hochdorf Swiss Nutrition

Last Friday, the extraordinary general meeting sealed Hochdorf’s fate as it approved the sale of Hochdorf Swiss Nutrition to AS Equity for 83 million Swiss francs.

  • Consortium Loan Deduction: 67 million Swiss francs
  • Net Proceeds to Hochdorf: 15.5 million Swiss francs

This transaction has been viewed critically; the proceeds from the sale are insufficient to cover the company’s existing debts, leading to predictions of a total loss for shareholders.

Market Reactions and Shareholder Impact

In the past month, Hochdorf’s share price has plummeted by an alarming 90%, now trading at approximately 70 cents. This decline in market value, alongside the reduced stake held by Newlat, emphasizes the volatility surrounding the company.

Current Market Value Overview

Metric Value
Share Price 70 cents
Market Value of Total Shares 1.5 million Swiss francs
Total Shares Outstanding 2.15 million

Future Prospects for Hochdorf

The sale of HSN marks a pivotal shift for Hochdorf as it looks to stabilize its operations moving forward. However, there are considerable risks involved for investors given its current financial state.

Expectations of total loss for shareholders create a bleak outlook. Stakeholders must now navigate an uncertain landscape as Hochdorf seeks restructuring opportunities that will stabilize its market presence.

Benefits of Understanding Market Dynamics

For investors and stakeholders, keeping abreast of market dynamics is crucial. Understanding the implications of such sales can provide insight into:

  • Investor Confidence: The reaction of the market and investor confidence can greatly influence share prices.
  • Company Valuation: Analyze how strategic decisions affect a company’s valuation.
  • Future Opportunities: Look out for potential restructuring efforts that could offer investment opportunities in the future.

Conclusion: The Ripple Effects

As Newlat steps back from Hochdorf, the aftermath will certainly be watched closely by market analysts and investors alike. The ongoing changes within the Swiss dairy processing sector are creating ripples that could affect not just Hochdorf, but the industry as a whole.

Leave a Replay